Preview Mode Links will not work in preview mode

The Retina Channel Podcast

Oct 23, 2017

Dr. Amin Kherani discusses the Clarity study which compares use of intravitreal aflibercept injections versus PRP laser for proliferative diabetic retinopathy. We also briefly discuss protocol S results that compare intravitreal ranibizumab versus PRP laser for the same indication.

Full reference of the Clarity article:

Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial. Sivaprasad, SobhaBhatnagar, A et al. The Lancet , Volume 389 , Issue 10085 , 2193 - 2203